Efficacy of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Other Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting β2-Agonist (ICS/LAMA/LABA) Triple Combinations in COPD: A Systematic Literature Review and Network Meta-analysis

被引：0
|
作者：
Gary T. Ferguson
Patrick Darken
Shaila Ballal
Mohd Kashif Siddiqui
Barinder Singh
Sumeet Attri
Ulf Holmgren
Enrico de Nigris
机构：
[1] Pulmonary Research Institute of Southeast Michigan,
[2] AstraZeneca,undefined
[3] Parexel International,undefined
[4] AstraZeneca,undefined
[5] AstraZeneca,undefined
来源：
Advances in Therapy | 2020年 / 37卷
关键词：
Chronic obstructive pulmonary disease; Exacerbations; Inhaled corticosteroid; Long-acting muscarinic antagonist; Long-acting β; -agonist; Lung function; Network meta-analysis; Patient-reported outcomes; Triple therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2956 / 2975
页数：19
相关论文
共 42 条
  • [41] Efficacy and safety of single-inhaler extrafine triple therapy versus inhaled corticosteroid plus long-acting beta2 agonist in eastern Asian patients with COPD: the TRIVERSYTI randomised controlled trial
    Zheng, Jinping
    Baldi, Simonetta
    Zhao, Li
    Li, Huiping
    Lee, Kwan-Ho
    Singh, Dave
    Papi, Alberto
    Grapin, Frederique
    Guasconi, Alessandro
    Georges, George
    RESPIRATORY RESEARCH, 2021, 22 (01)
  • [42] Efficacy and Tolerability of Insulin Degludec Versus Other Long-acting Basal Insulin Analogues in the Treatment of Type 1 and Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis
    Dong, Zhi-Yuan
    Feng, Ji-Hua
    Zhang, Jian-Feng
    CLINICAL THERAPEUTICS, 2022, 44 (11) : 1520 - 1533
12345